...
机译:慢性髓状瘤中的新兴翻译科学发现,克隆方法和治疗趋势
Tufts Univ Ctr Canc Div Hematol Oncol Boston MA 02111 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Fred Hutchinson Canc Ctr Fred Hutch Canc Res Ctr Seattle WA USA;
Univ Utah Div Hematol Oncol Salt Lake City UT USA;
Weill Cornell Med Div Pediat Hematol New York NY USA;
AP HP Ctr Invest Clin Paris France;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Stanford Canc Inst Div Hematol Stanford CA USA;
Med Univ Vienna Div Hematol &
Hemostaseol Dept Internal Med 1 Vienna Austria;
Chang Gung Mem Hosp Chiayi Taiwan;
Papa Giovanni XXIIII Hosp Fdn Clin Res Bergamo Italy;
Mem Sloan Kettering Canc Ctr Div Hematol 1275 York Ave New York NY 10021 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Rhein Westfal TH Aachen Dept Med 4 Fac Med Aachen Germany;
Orbassano Univ Hosp Div Hematol Turin Italy;
Univ Calif Irvine Div Hematol Oncol Irvine CA USA;
clonal heterogeneity; IFN alpha; inflammaging; investigational therapies; MPNs;
机译:慢性髓状瘤中的新兴翻译科学发现,克隆方法和治疗趋势
机译:慢性髓状瘤中的新兴翻译科学发现,克隆方法和治疗趋势
机译:新兴的治疗慢性费城染色体阴性的骨髓增生性肿瘤相关性骨髓纤维化的疗法
机译:心理障碍,临床和生物学参数与费城阴性慢性肌酚瘤肿瘤患者的相关性研究
机译:慢性骨髓增生性肿瘤钙网蛋白基因突变的临床和病理意义
机译:监测骨髓增生性肿瘤中的最小残留疾病:当前的应用和新兴的方法
机译:CSF3R-突变体克隆的产物在慢性髓性白血病患者中驱动第二个肌酚肿瘤:案例报告